Prognostically orientated multimodality treatment including surgery for selected patients of small-cell lung cancer patients stages IB to IIIB: long-term results of a phase II trial

Following mediastinoscopy, a prognostically orientated multimodality approach was chosen in selected small-cell lung cancer (SCLC) patients with hyperfractionated accelerated chemoradiotherapy (Hf-RTx) and definitive surgery (S). Stage IB/IIA patients had four cycles of cisplatin/etoposide (PE) and...

Descripción completa

Detalles Bibliográficos
Autores principales: Eberhardt, W, Stamatis, G, Stuschke, M, Wilke, H, Müller, M R, Kolks, S, Flasshove, M, Schütte, J, Stahl, M, Schlenger, L, Budach, V, Greschuchna, D, Stüben, G, Teschler, H, Sack, H, Seeber, S
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1999
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2374330/
https://www.ncbi.nlm.nih.gov/pubmed/10584883
http://dx.doi.org/10.1038/sj.bjc.6690830

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2374330/
https://www.ncbi.nlm.nih.gov/pubmed/10584883
http://dx.doi.org/10.1038/sj.bjc.6690830

Ejemplares similares